{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:38:02Z","timestamp":1780346282540,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Iran University of Medical Sciences, Iran, Islamic Republic Of","award":["14606"],"award-info":[{"award-number":["14606"]}]},{"name":"Iran University of Medical Sciences, Iran, Islamic Republic Of","award":["14606"],"award-info":[{"award-number":["14606"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-12474-6","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:34:26Z","timestamp":1741181666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cost-of-illness analysis of ulcerative colitis patients treated with biological therapy: a prospective observational study in Iran"],"prefix":"10.1186","volume":"25","author":[{"given":"Hassan","family":"Karami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Ghanbarnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Nowrouzpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mouseli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reihaneh","family":"Taheri Kondar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shirvani Shiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farbod","family":"Ebadi Fard Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"issue":"10080","key":"12474_CR1","first-page":"1756","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, et al. Ulcerative Colitis Lancet. 2017;389(10080):1756\u201370.","journal-title":"Ulcerative Colitis Lancet"},{"issue":"1","key":"12474_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17795\/acr-11480","volume":"1","author":"S Alireza Taghavi","year":"2013","unstructured":"Alireza Taghavi S, Reza Safarpour A, Hosseini SV, et al. Epidemiology of inflammatory bowel diseases (IBD) in Iran: a review of 740 patients in Fars Province, Southern Iran. Iran J Colorectal Res. 2013;1(1):1\u20132.","journal-title":"Iran J Colorectal Res"},{"issue":"2","key":"12474_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","volume":"152","author":"GG Kaplan","year":"2017","unstructured":"Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(2):313\u201321. e2.","journal-title":"Gastroenterology"},{"issue":"1","key":"12474_CR4","first-page":"29","volume":"5","author":"AA Shayesteh","year":"2013","unstructured":"Shayesteh AA, Saberifirozi M, Abedian S, et al. Epidemiological, demographic, and colonic extension ofulcerative colitis in Iran: A systematic review. Middle East J Dig Dis. 2013;5(1):29\u201336.","journal-title":"Middle East J Dig Dis"},{"issue":"10114","key":"12474_CR5","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769\u201378.","journal-title":"Lancet"},{"key":"12474_CR6","unstructured":"Zonderman J, Vender RS. Understanding Crohn\u2019s disease and ulcerative colitis. Univ. Press of Mississippi; 2009."},{"issue":"2","key":"12474_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5114\/aoms.2016.59254","volume":"12","author":"P Kawalec","year":"2016","unstructured":"Kawalec P. Indirect costs of inflammatory bowel diseases: Crohn\u2019s disease and ulcerative colitis. A systematic review. Arch Med Sci. 2016;12(2):295\u2013302.","journal-title":"Arch Med Sci"},{"issue":"5","key":"12474_CR8","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/MEG.0b013e328326cacb","volume":"21","author":"AK Waljee","year":"2009","unstructured":"Waljee AK, Joyce JC, Wren PA, et al. Patient-reported symptoms during an ulcerative colitis flare: a qualitative focus group study. Eur J Gastroenterol Hepatol. 2009;21(5):558\u201364.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"12474_CR9","doi-asserted-by":"crossref","unstructured":"Wetwittayakhlang P, Lontai L, Gonczi L et al. Treatment targets in ulcerative colitis: is it time for all in, including histology?? J Clin Med. 2021;10(23):5551.","DOI":"10.3390\/jcm10235551"},{"issue":"37","key":"12474_CR10","doi-asserted-by":"publisher","first-page":"13234","DOI":"10.3748\/wjg.v20.i37.13234","volume":"20","author":"GS Seo","year":"2014","unstructured":"Seo GS, Chae SC. Biological therapy for ulcerative colitis: an update. World J Gastroenterol. 2014;20(37):13234\u20138.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"12474_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5009\/gnl14226","volume":"9","author":"SC Park","year":"2015","unstructured":"Park SC, Jeen YT. Current and emerging biologics for ulcerative colitis. Gut Liver. 2015;9(1):18\u201327.","journal-title":"Gut Liver"},{"issue":"5","key":"12474_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/gut.2006.103564","volume":"56","author":"G D\u2019Haens","year":"2007","unstructured":"D\u2019Haens G. Risks and benefits of biologic therapy for inflammatory bowel diseases. Gut. 2007;56(5):725\u201332.","journal-title":"Gut"},{"issue":"2","key":"12474_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(21)00377-0","volume":"7","author":"JS Lasa","year":"2022","unstructured":"Lasa JS, Olivera PA, Danese S, et al. Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(2):161\u201370.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"12474_CR14","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.cgh.2019.07.022","volume":"18","author":"GR Lichtenstein","year":"2020","unstructured":"Lichtenstein GR, Shahabi A, Seabury SA, et al. Lifetime economic burden of Crohn\u2019s disease and ulcerative colitis by age at diagnosis. Clin Gastroenterol Hepatol. 2020;18(4):889\u2013e89710.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"12474_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.34172\/aim.2023.04","volume":"26","author":"L Rahmati","year":"2023","unstructured":"Rahmati L, Mooghali A, Kamani SMH, et al. Economic burden of inflammatory bowel disease in Shiraz, Iran. Arch Iran Med. 2023;26(1):23\u20138.","journal-title":"Arch Iran Med"},{"issue":"1","key":"12474_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12876-023-02648-z","volume":"23","author":"M Pakdin","year":"2023","unstructured":"Pakdin M, Zarei L, Bagheri Lankarani K, et al. The cost of illness analysis of inflammatory bowel disease. BMC Gastroenterol. 2023;23(1):21. 2023\/01\/19.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"12474_CR17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.5217\/ir.2018.00157","volume":"17","author":"MM Malekzadeh","year":"2019","unstructured":"Malekzadeh MM, Sima A, Alatab S, et al. Iranian registry of Crohn\u2019s and colitis: study profile of first nation-wide inflammatory bowel disease registry in the middle East. Intest Res. 2019;17(3):330\u20139.","journal-title":"Intest Res"},{"issue":"4","key":"12474_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.34172\/aim.2024.27","volume":"27","author":"B Saberzadeh-Ardestani","year":"2024","unstructured":"Saberzadeh-Ardestani B, Khosravi AA, Mansour-Ghanaei F, et al. Clinical phenotype and disease course of inflammatory bowel disease in Iran: results of the Iranian registry of Crohn\u2019s and colitis (IRCC). Arch Iran Med. 2024;27(4):183.","journal-title":"Arch Iran Med"},{"issue":"1","key":"12474_CR19","first-page":"6","volume":"11","author":"PW Petryszyn","year":"2016","unstructured":"Petryszyn PW, Witczak I. Costs in inflammatory bowel diseases. Gastroenterol Review\/Przegl\u0105d Gastroenterologiczny. 2016;11(1):6\u201313.","journal-title":"Gastroenterol Review\/Przegl\u0105d Gastroenterologiczny"},{"issue":"sup170","key":"12474_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/00365528909091339","volume":"24","author":"J Lennard-Jones","year":"1989","unstructured":"Lennard-Jones J. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24(sup170):2\u20136.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"12474_CR21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/heart.88.6.597","volume":"88","author":"JL Liu","year":"2002","unstructured":"Liu JL, Maniadakis N, Gray A, et al. The economic burden of coronary heart disease in the UK. Heart. 2002;88(6):597\u2013603.","journal-title":"Heart"},{"key":"12474_CR22","doi-asserted-by":"crossref","unstructured":"Zare F, Fattahi MR, Sepehrimanesh M et al. Economic burden of hepatitis C virus infection in different stages of disease: A report from Southern Iran. Hepat Monthly. 2016;16(4):e32654.","DOI":"10.5812\/hepatmon.32654"},{"issue":"4","key":"12474_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000525206","volume":"30","author":"F Magro","year":"2022","unstructured":"Magro F, Portela F, Lago P, et al. Burden of disease and cost of illness of inflammatory bowel diseases in Portugal. GE - Portuguese J Gastroenterol. 2022;30(4):283\u201392.","journal-title":"GE - Portuguese J Gastroenterol"},{"key":"12474_CR24","doi-asserted-by":"crossref","unstructured":"Kappelman MD, Rifas\u2013Shiman SL, Porter CQ et al. Direct Health Care Costs of Crohn\u2019s Disease and Ulcerative Colitis in US Children and Adults. Gastroenterology. 2008;135(6):1907\u20131913.","DOI":"10.1053\/j.gastro.2008.09.012"},{"key":"12474_CR25","unstructured":"Capri S, Russo A. The costs of patients with inflammatory bowel diseases (Crohn\u2019s disease and ulcerative colitis). Real-world study in Italy. Global Reg Health Technol Assess. 2018;5(1)."},{"issue":"7","key":"12474_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1365-2036.2010.04234.x","volume":"31","author":"RD COHEN","year":"2010","unstructured":"COHEN RD, YU AP, WU EQ, et al. Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther. 2010;31(7):693\u2013707.","journal-title":"Aliment Pharmacol Ther"},{"key":"12474_CR27","doi-asserted-by":"crossref","unstructured":"Kamat N, Ganesh Pai C, Surulivel Rajan M et al. Cost of illness in inflammatory bowel disease. Dig Dis Sci. 2017;62(9):2318\u201326.","DOI":"10.1007\/s10620-017-4690-z"},{"key":"12474_CR28","doi-asserted-by":"crossref","unstructured":"Bodger K. Cost of Illness of Crohn\u2019s Disease. PharmacoEconomics. 2002;20(10):639\u2013652.","DOI":"10.2165\/00019053-200220100-00001"},{"issue":"17","key":"12474_CR29","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.3748\/wjg.15.2081","volume":"15","author":"AJ Lucendo","year":"2009","unstructured":"Lucendo AJ, De Rezende LC. Importance of nutrition in inflammatory bowel disease. World J Gastroenterol. 2009;15(17):2081\u20138.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"12474_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/nu12020372","volume":"12","author":"P Balestrieri","year":"2020","unstructured":"Balestrieri P, Ribolsi M, Guarino MPL, et al. Nutritional aspects in inflammatory bowel diseases. Nutrients. 2020;12(2):372.","journal-title":"Nutrients"},{"key":"12474_CR31","doi-asserted-by":"crossref","unstructured":"Stark R, K\u00f6nig H-H, Leidl R. Costs of inflammatory bowel disease in Germany. PharmacoEconomics. 2006;24(8):797\u2013814.","DOI":"10.2165\/00019053-200624080-00006"},{"issue":"1","key":"12474_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/gutjnl-2012-303376","volume":"63","author":"ME van der Valk","year":"2014","unstructured":"van der Valk ME, Mangen M-JJ, Leenders M, et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF\u03b1 therapy: results from the COIN study. Gut. 2014;63(1):72\u20139.","journal-title":"Gut"},{"issue":"7","key":"12474_CR33","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1177\/2050640619853448","volume":"7","author":"J Lawton","year":"2019","unstructured":"Lawton J, Achit H, Pouillon L, et al. Cost-of-illness of inflammatory bowel disease patients treated with anti-tumour necrosis factor: A French large single-centre experience. United Eur Gastroenterol J. 2019;7(7):908\u201313.","journal-title":"United Eur Gastroenterol J"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12474-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-12474-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12474-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:34:33Z","timestamp":1741181673000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-12474-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12474"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-12474-6","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical committee of Iran University of Medical Sciences approved this study (IR.IUMS.MEDICINE.REC.1398.222). The study was conducted in full compliance with the ethical principles outlined in the Declaration of Helsinki and adhered to all applicable national guidelines. Informed consent was obtained from all participants before their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}